Industry Gives Positive Outlook on Increased Domestic OTC Sales

Published: 2005-01-20 06:59:00

Updated: 2005-01-20 06:59:00

The pharmaceutical industry is making its positive outlook on increased domestic sales activity of over-the-counter (OTC) products, based on a recent announcement by the government to allow for public advertising of certain OTC medications that were previously banned under the therapeutic group s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK